Thursday, February 02, 2006


Hep C Virus - VX-950 To Get Fast Tracked


VX-950 To Get Fast Tracked
As you may recall we've been saying VX-950 is the revolutionary new therapy to watch for HCV. Now it looks like the FDA agrees this treatment is quite promising and deserving of faster approval than a lesser worthy approach. Another...

Hepatitis C Patients Taxing Medical System
Title: Hepatitis C Patients Taxing Medical SystemCategory: Health NewsCreated: 12/31/2005 1:59:00 AMLast Editorial Review: 12/31/2005 1:58:37 AM

Ultrasound
Title: UltrasoundCategory: Procedures and TestsCreated: 12/31/1997Last Editorial Review: 10/15/2005

Vertex Progresses with VX-950
Vertex is the racehorse to watch right now. They are progressing quicky on their preliminary good results. While it's not yet time to line up for their treatment, we believe theirs will be first to market of the new approaches...

Shorter Therapy Effective for Genotypes 2 and 3
Genotypes 2 and 3 are much more responsive to current interferon combination therapies. This report details studies that show a shorter course of treatment might be just as effective as longer courses. Researchers continue to refine treatment protocols for HCV...